Pharmacovigilance is the science and practice of detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems.

Nausea and vomiting are the most common adverse drug reactions, occurring in up to 30% of patients taking medications.

A pharmacovigilance risk management plan is a comprehensive document that outlines the steps that will be taken to identify, assess, minimize, and monitor the risks associated with a medicine.

Clinical trials are not a method for collecting adverse drug reaction reports because they are designed to evaluate the efficacy and safety of a medicine before it is marketed.

A risk management plan for a medical device is a comprehensive document that outlines the steps that will be taken to identify, assess, minimize, and monitor the risks associated with the medical device.

The risk-benefit ratio of a medicine is the most important factor to consider when evaluating its safety because it takes into account both the benefits of the medicine and the risks associated with it.

A pharmacovigilance committee is a group of experts who are responsible for reviewing and evaluating adverse drug reaction reports, making recommendations for changes to the labeling of a medicine, and developing and implementing pharmacovigilance risk management plans.

A medication guide is a document that provides information about the safe use of a medicine, including the potential side effects, how to store the medicine, and how to take the medicine correctly.

Patients play an important role in pharmacovigilance by reporting any adverse drug reactions they experience, providing information about their medical history, and following the instructions for taking their medicine correctly.

A serious adverse drug reaction is one that results in death, a life-threatening illness, or permanent disability, while a non-serious adverse drug reaction is one that does not result in death, a life-threatening illness, or permanent disability.

Regulatory authorities play an important role in pharmacovigilance by reviewing and approving new medicines, monitoring the safety of medicines after they have been marketed, and taking action to protect the public from unsafe medicines.

Pharmacovigilance databases are used to collect and store adverse drug reaction reports, analyze adverse drug reaction reports, and identify trends in adverse drug reactions.

Healthcare professionals play an important role in pharmacovigilance by reporting any adverse drug reactions they observe, providing information about their patients' medical history, and following the instructions for prescribing and dispensing medicines correctly.

A risk management plan for a vaccine is a comprehensive document that outlines the steps that will be taken to identify, assess, minimize, and monitor the risks associated with the vaccine.

Pharmacovigilance working groups are groups of experts who are responsible for developing and implementing pharmacovigilance plans, reviewing and evaluating adverse drug reaction reports, and making recommendations for changes to the labeling of a medicine.